Kumar Santosh, Sanyal Debmalya, Das Pratik, Bhattacharjee Kingshuk, Rungta Rohit
Department of Nephrology, Rabindranath Tagore International Institute of Cardiac Sciences, EM Bypass, Kolkata, West Bengal, India.
Department of Endocrinology, KPC Medical College, Jadavpur, Kolkata, West Bengal, India.
Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):610-615. doi: 10.4103/ijem.IJEM_121_18.
This study aimed to determine the pre-transplant risk factors as independent predictors on the new-onset of diabetes mellitus after renal transplants (NODATs).
A single-centred prospective real-world observational study of 100 subjects who underwent renal transplantation over a period of 2 years. All known patients with diabetes were excluded from the study. NODAT was defined according to the American Diabetes Association definition. In addition to pre-transplant workup 2 days prior to transplant, post-transplant follow-up done on weekly basis for 1 month, every 15 day from 1 month to 3 month, monthly from 3 month to 12 month. Each transplant patient followed up for 1 year post-transplant or for 6 months post-development of NODAT, whichever was later. All the pre-transplant variables namely body mass index (BMI), family history of diabetes mellitus (DM), HbA1c, fasting insulin level, fasting c-peptide level, serology for hepatitis B, C, serum magnesium level and pre-operative insulin ressistance were further compared between NODAT and non-NODAT groups at the end of the study to assess their strength of associations.
Among the 100 subjects included in the study, 24 developed NODAT. Risk factors namely age, family history of DM, BMI, hepatitis B and C infection, total cholesterol, triglyceride level, pre-operative HbA1c, pre-operative insulin resistance and pre-diabetes were significantly higher, whereas beta-cell function, ABO compatibility and magnesium levels being significantly lower in NODAT cohort.
The incidence of NODAT is quite high (24%). Risk of development of NODAT was related to traditional as well as novel risk factors. Key aspects lies in identifying patients at risk of developing NODAT, using traditional risk factors for early diagnosis and introducing interventions on modifiable risk factors for prevention and timely intervention.
本研究旨在确定肾移植后新发糖尿病(NODAT)的移植前危险因素作为独立预测因素。
一项单中心前瞻性真实世界观察性研究,研究对象为2年内接受肾移植的100名受试者。所有已知糖尿病患者均被排除在研究之外。NODAT根据美国糖尿病协会的定义进行定义。除了移植前2天的移植前检查外,移植后第1个月每周进行随访,第1个月至第3个月每15天进行一次随访,第3个月至第12个月每月进行一次随访。每位移植患者在移植后随访1年或在NODAT发生后随访6个月,以较晚者为准。在研究结束时,进一步比较NODAT组和非NODAT组之间所有移植前变量,即体重指数(BMI)、糖尿病家族史(DM)、糖化血红蛋白(HbA1c)、空腹胰岛素水平、空腹C肽水平、乙肝、丙肝血清学、血清镁水平和术前胰岛素抵抗,以评估它们的关联强度。
在纳入研究的100名受试者中,24人发生了NODAT。危险因素,即年龄、DM家族史、BMI、乙肝和丙肝感染、总胆固醇、甘油三酯水平、术前HbA1c、术前胰岛素抵抗和糖尿病前期在NODAT队列中显著更高,而β细胞功能、ABO相容性和镁水平在NODAT队列中显著更低。
NODAT的发生率相当高(24%)。NODAT发生的风险与传统和新的危险因素有关。关键在于识别有发生NODAT风险的患者,利用传统危险因素进行早期诊断,并对可改变的危险因素采取干预措施进行预防和及时干预。